<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>Androgenetic alopecia</italic> (AGA) could possibly be related to SARS‐CoV‐2 infection as both conditions are considered to be androgen mediated.
 <xref rid="ijd15189-bib-0060" ref-type="ref">
  <sup>60</sup>
 </xref> Clinically significant AGA was found in 29 (71%) of the 41 Caucasian men with bilateral SARS‐CoV‐2 pneumonia hospitalized in two tertiary Spanish hospitals. In comparison, the prevalence of AGA among healthy Spanish Caucasian men was estimated at approximately 31–53%.
 <xref rid="ijd15189-bib-0061" ref-type="ref">
  <sup>61</sup>
 </xref> Future case‐controlled studies may potentially confirm AGA as a predictive factor for increased COVID‐19 severity and contribute to the development of antiandrogen therapy for SARS‐CoV‐2 infection.
 <xref rid="ijd15189-bib-0062" ref-type="ref">
  <sup>62</sup>
 </xref>
</p>
